Adrian Bot
MD, PhD
Vice President of Translational Sciences
👥Biography 个人简介
Adrian Bot has been instrumental in translating CAR-T cell therapy from academic research to commercial manufacturing at Kite Pharma, leading the process development and characterization of axicabtagene ciloleucel through FDA approval. His team developed the rapid manufacturing process that reduced vein-to-vein time and improved product consistency for commercial-scale CAR-T production. He continues to advance next-generation manufacturing platforms incorporating automation and real-time process analytics.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Adrian Bot 的研究动态
Follow Adrian Bot's research updates
留下邮箱，当我们发布与 Adrian Bot（Kite Pharma / Gilead Sciences）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment